Comparative analysis of Apo(A) gene alleles: Distribution of pentanucleotide repeats in position -1373 and C/T transition in position +93 among patients with myocardial infarction and a control group in St. Petersburg, Russia

Biochemical and Molecular Medicine

Volumn 61, Issue 2, 1997, Pages 208-213

  Volkova, Maria V ^a   Vasina, Valentina I ^a   Fomicheva, Ekaterina V ^a   Schwartz, Eugene I ^a  

^a PETERSBURG NUCLEAR PHYSICS INSTITUTE   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA FLANKING REGION; DNA POLYMORPHISM; GENE CONTROL; GENE EXPRESSION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; SITE DIRECTED MUTAGENESIS;

EID: 0031214163     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1997.2582     Document Type: Article

References (16)

1. Schaefer E J, Lamon-Fava S, Jenner J L, McNamara J R, Ordovas J M, Davis E, Abolafia J M, Lippel K, Levy R I. Lipoprotein(a) levels and risk of coronary heart disease in men. J Am Med Assoc. 271:1994;999-1003.
2. Wilhemsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein (a) and coronary heart disease: A prospective case-control study in a general population sample of middle aged men. BMJ. 301:1990;1248-1251.
3. Albers J J, Adolphson J, Hazzard W. Radio-immunoassay of human plasma Lp(a) lipoprotein. J Lipid Res. 18:1977;331-338.
4. McLean J W, Tomlinson J E, Kuang W-J, Eaton D L, Chen E Y, Fless G M, Scanu A M, Lawn R M. Human apolipiprotein (a): cDNA sequence of an apolipoprotein homologous to plasminogen. Nature. 330:1987;132-137.
5. Boerwinkle E, Leffert C, Lin J, Lackner C, Chiesa G, Hobbs H H. Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentrations. J Clin Invest. 90:1992;52-606.
6. Sandholzer C, Hallman D, Saha N, Sigurdsson G, Lackner A, Csaszar A, Boerwinkle E, Utermann G. Effects of apolipoprotein (a) size polymorphism on the lipoprotein (a) concentration in 7 ethnic groups. Hum Genet. 86:1991;607-614.
7. Utermann G, Haibach C, Trommsdorf M, Kochl S, Lingenhel A, Abe A, Kraft H G. Genetic architecture of the atherogenic lipoprotein (a). Ann NY Acad Sci. 748:1995;301-311.
8. Trommsdorff M, Kochl S, Lingenhel A, Kronenberg F, Delport R, Vermaak H, Lemming L, Clausen I C, Faergeman O, Utermann G, Kraft H-G. A pentanucleotide repeat polymorphism in the 5′ control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J Clin Invest. 96:1995;150-157.
9. Amemiya H, Arinami T, Kikuchi S, Yamakawa-Kobayashi K, Li L, Fujiwara H, Hiroe M, Marumo F, Hamaguchi H. Apolipoprotein(a) size and pentanucleotide repeat polymorphism are associated with the degree of atherosclerosis in coronary heart disease. Atherosclerosis. 123:1996;181-191.
10. Zysov B, Lindahl G, Wade D, Knight B, Lawn R. C/T polymorphism in the 5′ untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation. Arterioscler Tromb Vasc Biol. 15:1995;58-64.
11. Volkova M, Vasina V, Obraztsova G, Schwartz E. Identification of the C/T polymorphism in the +93 position of the apo(a) gene by mismatch PCR-mediated site-directed mutagenesis and restriction enzyme digestion. Biochem Mol Med. 59:1996;91-92.
12. Sunayama S, Daida H, Mokuno H, Miyano H, Yokoi H, Lee Y J, Sakurai H, Yamaguchi H. Lack of increased coronary atherosclerotic risk due to elevated lipoprotein(a) in women ≥55 years of age. Circulation. 94:1996;1263-1268.
13. Wang X L, McCredie R M, Wilcken D EL. Genotype distribution of angiotensin-converting enzyme polymorphism in Australian healthy and coronary populations and relevance to myocardial infarction and coronary artery disease. Arterioscler Tromb Vasc Biol. 16:1996;115-119.
14. Berg K. A new serum type system in man: The Lp system. Acta Pathol Microbiol Scand. 59:1963;369-382.
15. Harpel P C, Hermann A, Zhang X, Ostfeld I, Borth W. Lipoprotein(a), plasmin modulation, and atherogenesis. Thromb Haem. 74:1995;382-386.
16. Enas E A. Angiographic progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation. 92:1995;2353-2354.